Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 · Mkt capMarket cap $33.17B · View financials
Snapshot Sep 4, 4:00 PM ET
Decision snapshot: DXCM stock price vs JCI: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at JCI's multiple
Needs JCI P/E.
Implied fair value · at DXCM's multiple
Needs DXCM P/E.
Snapshot Sep 4, 4:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Pricing power
Operating leverage
Multiple premium
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: DXCM FY 2025 (ended Dec 31, 2025) · JCI FY 2025 (ended Sep 30, 2025). Fiscal years are not aligned.
Trendline
Ten fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Capital structure 91% equity / 9% debt · EV / Revenue 7.63x · EV / EBITDA 26.75x
Capital structure 90% equity / 10% debt · EV / Revenue 4.15x · EV / EBITDA 22.80x
JCI carries the larger enterprise value at $97.97B against $35.57B; JCI trades on the lower EV / Revenue multiple (4.15x vs 7.63x); JCI on the lower EV / EBITDA (22.80x vs 26.75x).
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
DEXCOM, INC. · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
JOHNSON CONTROLS INTERNATIONAL PLC · implied price per share
Bear
$15.00
Base
$20.10
Bull
$27.78
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
1.21x
0.77x
Net debt / EBITDA
Leverage against operating earnings
1.81x
2.22x
Cash and equivalents
Liquid reserves on the balance sheet
$917.70M
$379.00M
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
ABBOTT LABORATORIES
DXCM vs ABT
Medtronic plc
DXCM vs MDT
BECTON DICKINSON & CO
DXCM vs BDX
CARRIER GLOBAL Corp
DXCM vs CARR
AAON, INC.
DXCM vs AAON
COMFORT SYSTEMS USA INC
DXCM vs FIX
Trane Technologies plc
DXCM vs TT
LENNOX INTERNATIONAL INC
DXCM vs LII
Allegion plc
DXCM vs ALLE
$3.32B
$9.92B
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.
